34 While our findings align with the recognized impact of disease severity and systemic inflammation (e.g., elevated CRP) on hospitalization risk, they differ in suggesting that prior IBD medication use, including immunosuppressants, does not significantly contribute to this risk. The gene discussed is CRP; the disease is inflammatory bowel disease.